ALIVUS LIFE SCIENCES
Back to Cashflow Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-64 Cr | ₹-6.23 Cr | ₹-279 Cr | ₹-388 Cr | ₹-79 Cr |
What is the latest Cash Flow from Financing Activities ratio of ALIVUS LIFE SCIENCES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-64 Cr |
| Mar2025 | ₹-6.23 Cr |
| Mar2024 | ₹-279 Cr |
| Mar2023 | ₹-388 Cr |
| Mar2022 | ₹-79 Cr |
How is Cash Flow from Financing Activities of ALIVUS LIFE SCIENCES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-64 Cr | Negative | |
| Mar2025 | ₹-6.23 Cr | Negative | |
| Mar2024 | ₹-279 Cr | Negative | |
| Mar2023 | ₹-388 Cr | Negative | |
| Mar2022 | ₹-79 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹16,826.1 Cr | -1% | 20.5% | 43.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -1% |
20.5% |
43.2% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses